GIP receptor agonism blocks chemotherapy-induced nausea and vomiting

OBJECTIVE: Nausea and vomiting remain life-threatening obstacles to successful treatment of chronic diseases, despite a cadre of available antiemetic medications. Our inability to effectively control chemotherapy-induced nausea and vomiting (CINV) highlights the need to anatomically, molecularly, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Borner, Tito, Reiner, Benjamin C., Crist, Richard C., Furst, C. Daniel, Doebley, Sarah A., Halas, Julia G., Ai, Minrong, Samms, Ricardo J., De Jonghe, Bart C., Hayes, Matthew R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326744/
https://www.ncbi.nlm.nih.gov/pubmed/37245848
http://dx.doi.org/10.1016/j.molmet.2023.101743

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326744/
https://www.ncbi.nlm.nih.gov/pubmed/37245848
http://dx.doi.org/10.1016/j.molmet.2023.101743

Ejemplares similares